EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Clinical Characteristics, Genetic Spectrum, and Treatment Outcomes in Children With Primary Hyperoxaluria: Results From a National Turkish Registry

Elifsu Gözde Akbörü, Emre Leventoğlu, Seda Pınarbaşı, Mehtap Akbalık Kara, Beltinge Demircioğlu Kılıç, Yılmaz Tabel, Aysun Karabay Beyazıt iD, Nurdan Yıldız, Nilüfer Göknar, İsmail Dursun, Hülya Nalçacıoğlu, Rezan Topaloğlu und 9 weitere

Pediatric Transplantation · 2026

DOI: 10.1111/petr.70401 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pediatric Transplantation, 2026. Verfasst von Elifsu Gözde Akbörü und 20 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Pediatrics, Gazi University, Ankara, Türkiye. Hauptthemen laut MEDLINE: Hyperoxaluria, Primary. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Gen İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Primary hyperoxaluria (PH) is a rare autosomal recessive disorder characterized by excessive oxalate production, leading to nephrolithiasis, nephrocalcinosis, and kidney failure. Data from large pediatric cohorts remain limited.

Methods

This national, multicenter, retrospective study included 88 pediatric patients with PH followed in 15 centers in Türkiye between 2010 and 2024. Clinical, genetic, and treatment‐related data were collected via a web‐based registry, and disease progression and outcomes were analyzed.

Results

The median age at diagnosis was 2.6 (IQR: 0.5–8.4) years in PH1, with an approximate diagnostic delay of 2 years. At diagnosis, nearly half (49.4%) had kidney failure. Genetic diagnosis was performed in 59 (71.1%) patients. The most frequently detected variants were p.Val324Glyfs ( n = 12, 20.3%) and p.Gly170Arg ( n = 9, 15.2%). During a median follow‐up of 58 months (IQR: 24–109), dialysis was initiated at 51.8% and mortality reached 27.7%, particularly among patients presenting with kidney failure. Pyridoxine was used in 55.4% of patients, although response rates were limited, partly due to late diagnosis and non‐genotype‐guided use. Transplantation was performed in 24.1% of patients. Sequential liver–kidney transplantation provided favorable long‐term renal outcomes and remains the most effective treatment for advanced disease by correcting the underlying metabolic defect. Patients with PH2 and PH3 exhibited a milder clinical course, preserved kidney function, and no mortality during follow‐up.

Conclusions

Delayed diagnosis remains a major challenge in pediatric PH. Early recognition, genotype‐guided therapy, and timely implementation of appropriate transplantation strategies are essential to improve outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperoxaluria, PrimaryChildChild, PreschoolFemaleHumansInfantMaleDisease ProgressionFollow-Up StudiesKidney TransplantationLiver TransplantationRegistriesRetrospective StudiesTreatment OutcomeTurkey

Stichwörter der Autor:innen

childrenprimary hyperoxaluriapyridoxinesequential liver–kidney transplantation

Autor:innen und Institutionen

  • Faculty of Medicine, Department of Pediatrics, Gazi University, Ankara, Türkiye.
  • Faculty of Medicine, Department of Pediatrics, Division of Nephrology, Gazi University, Ankara, Türkiye.
  • Department of Pediatric Nephrology, Diyarbakır Children Hospital, Diyarbakır, Türkiye.
  • Faculty of Medicine, Department of Pediatric Nephrology, Gaziantep University, Gaziantep, Türkiye.
  • Faculty of Medicine, Department of Pediatric Nephrology, İnönü University, Malatya, Türkiye.
  • Faculty of Medicine, Department of Pediatric Nephrology, Çukurova University, Adana, Türkiye.

ORCID-Profile: Aysun Karabay Beyazıt, Bağdagül Aksu, Serçin Güven, Sevcan A Bakkaloğlu

Förderung

  • Gen İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş.

Zitieren

APA

Akbörü, E. G., Leventoğlu, E., Pınarbaşı, S., Kara, M. A., Kılıç, B. D., Tabel, Y., Beyazıt, A. K., Yıldız, N., Göknar, N., Dursun, İ., Nalçacıoğlu, H., Topaloğlu, R., Aksu, B., Alparslan, C., Benzer, M., Güven, S., Kara, A., Kavaz, A., Noyan, A., …, & Bakkaloğlu, S. A. (2026). Clinical Characteristics, Genetic Spectrum, and Treatment Outcomes in Children With Primary Hyperoxaluria: Results From a National Turkish Registry. Pediatric Transplantation. https://doi.org/10.1111/petr.70401

Vancouver

Akbörü EG, Leventoğlu E, Pınarbaşı S, Kara MA, Kılıç BD, Tabel Y, et al. Clinical Characteristics, Genetic Spectrum, and Treatment Outcomes in Children With Primary Hyperoxaluria: Results From a National Turkish Registry. Pediatric Transplantation. 2026. doi:10.1111/petr.70401

BibTeX
@article{Akbr2026,
  author = {Akbörü, Elifsu Gözde and Leventoğlu, Emre and Pınarbaşı, Seda and Kara, Mehtap Akbalık and Kılıç, Beltinge Demircioğlu and Tabel, Yılmaz and Beyazıt, Aysun Karabay and Yıldız, Nurdan and Göknar, Nilüfer and Dursun, İsmail and Nalçacıoğlu, Hülya and Topaloğlu, Rezan and Aksu, Bağdagül and Alparslan, Caner and Benzer, Meryem and Güven, Serçin and Kara, Aslıhan and Kavaz, Aslı and Noyan, Aytül and Sakallıoğlu, Onur and Bakkaloğlu, Sevcan A},
  title = {Clinical Characteristics, Genetic Spectrum, and Treatment Outcomes in Children With Primary Hyperoxaluria: Results From a National Turkish Registry},
  journal = {Pediatric Transplantation},
  year = {2026},
  doi = {10.1111/petr.70401}
}
Kostenlos starten →